Abstract
A novel near-infrared fluorescent light-up probe with a tumor-homing pentapeptide, CREKA (Cys-Arg-Glu-Lys-Ala), specifically binds to fibrin-fibronectin complexes was rationally designed and developed for biomedical imaging. Its superior practical applications in tumor imaging and drug-induced liver injury detection are well demonstrated for the first time.
Original language | English |
---|---|
Pages (from-to) | 2541-2544 |
Number of pages | 4 |
Journal | Chemical Communications |
Volume | 55 |
Issue number | 17 |
Early online date | 30 Jan 2019 |
DOIs | |
Publication status | Published - 28 Feb 2019 |